272 related articles for article (PubMed ID: 33558424)
1. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
Lee IS; Lee H; Hur H; Kanda M; Yook JH; Kim BS; Woo Y; Kodera Y; Kim K; Goel A
Clin Cancer Res; 2021 Apr; 27(8):2292-2300. PubMed ID: 33558424
[TBL] [Abstract][Full Text] [Related]
2. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer.
Lee IS; Sahu D; Hur H; Yook JH; Kim BS; Goel A
Gastric Cancer; 2021 May; 24(3):655-665. PubMed ID: 33523340
[TBL] [Abstract][Full Text] [Related]
3. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
4. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
[TBL] [Abstract][Full Text] [Related]
5. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
6. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
[TBL] [Abstract][Full Text] [Related]
7. Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning.
Zhou C; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
Cancer Control; 2020; 27(1):1073274820968900. PubMed ID: 33115287
[TBL] [Abstract][Full Text] [Related]
8. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
[TBL] [Abstract][Full Text] [Related]
9. A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases.
Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Baba H; Mori M; Goel A
Eur J Cancer; 2022 Mar; 163():66-76. PubMed ID: 35042069
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
11. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer.
Takeno A; Takemasa I; Seno S; Yamasaki M; Motoori M; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Nishida T; Okayama T; Matsubara K; Takenaka Y; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Apr; 17(4):1033-42. PubMed ID: 20012501
[TBL] [Abstract][Full Text] [Related]
15. LncRNA expression signature identified using genome-wide transcriptomic profiling to predict lymph node metastasis in patients with stage T1 and T2 gastric cancer.
Dong ZB; Xiang HT; Wu HM; Cai XL; Chen ZW; Chen SS; He YC; Li H; Yu WM; Liang C
Gastric Cancer; 2023 Nov; 26(6):947-957. PubMed ID: 37691031
[TBL] [Abstract][Full Text] [Related]
16. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
17. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
Shin SJ; Park S; Kim MH; Nam CM; Kim H; Choi YY; Jung MK; Choi HJ; Rha SY; Chung HC
Oncologist; 2019 Nov; 24(11):e1108-e1114. PubMed ID: 31015316
[TBL] [Abstract][Full Text] [Related]
19. Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
Belia F; Kim KY; Agnes A; Park SH; Cho M; Kim YM; Kim HI; Persiani R; D'Ugo D; Biondi A; Hyung WJ
Eur J Surg Oncol; 2024 Jun; 50(6):108359. PubMed ID: 38657377
[TBL] [Abstract][Full Text] [Related]
20. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]